6-Chloropyridazin-3-ol → 6-Chloro-2-methyl-2,3-dihydropyridazin-3-one
Reaction equation
[CH3:1][C:2]([CH3:36])([CH2:5][C@@:6]1([C:30]2[CH:35]=[CH:34][CH:33]=[CH:32][CH:31]=2)[O:11][C:10](=[O:12])[N:9]([C@H:13]([C:15]2[CH:20]=[CH:19][C:18](B3OC(C)(C)C(C)(C)O3)=[CH:17][CH:16]=2)[CH3:14])[CH2:8][CH2:7]1)[C:3]#[N:4].[Cl:37][C:38]1[CH:39]=[CH:40][C:41](=[O:45])[N:42]([CH3:44])[N:43]=1.ClC1C=CC(=O)NN=1>>[CH3:1][C:2]([CH3:36])([CH2:5][C@@:6]1([C:30]2[CH:35]=[CH:34][CH:33]=[CH:32][CH:31]=2)[O:11][C:10](=[O:12])[N:9]([C@H:13]([C:15]2[CH:20]=[CH:19][C:18]([C:38]3[CH:39]=[CH:40][C:41](=[O:45])[N:42]([CH3:44])[N:43]=3)=[CH:17][CH:16]=2)[CH3:14])[CH2:8][CH2:7]1)[C:3]#[N:4].[Cl:37][C:38]1[CH:39]=[CH:40][C:41](=[O:45])[N:42]([CH3:44])[N:43]=1Participants
5
Reactant 3
Product 2
Procedure
The title compound was prepared from 2,2-dimethyl-3-((R)-2-oxo-6-phenyl-3-((S)-1-(4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)phenyl)ethyl)-1,3-oxazinan-6-yl)propanenitrile and 6-chloro-2-methylpyridazin-3(2H)-one following a procedure analogous to that described in Example 1 Step 3. 6-chloro-2-methylpyridazin-3(2H)-one was prepared from 6-chloropyridazin-3-(2H)-one following a procedure analogous to that described in Example 1 Step 2. LC-MS Method 2 tR=1.138 min, m/z=471.3; 1H NMR (CDCl3) 1.28 (s, 3H), 1.41 (s, 3H), 1.49 (m, 3H), 2.1 (s, 2H), 2.2 (m, 1H), 2.42 (m, 2H), 2.85 (m, 1H), 3.78 (s, 3H), 6.92 (m, 3H), 7.31 (m, 5H), 7.43 (d, 2H), 7.50 (d, 1H), 7.35 (m, 8H)
Sources & evidence
- ORD record
- ord-7f45304120a6473fb821bce2aee40565
- Source dataset
- uspto-grants-2013_11
- Patent number
- US08592410B2
Reaction notes
Loading…